<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl12675</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-12675</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical endocrinology</subject></subj-group></article-categories><title-group><article-title>Результаты анализа базы данных пациентов с гипопаратиреозом ФГБУ «НМИЦ эндокринологии» Минздрава России</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of chronic hypoparathyroidism course according to the Database of Endocrinology Research Centre</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9258-2591</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковалева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovaleva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ковалева Елена Владимировна - научный сотрудник отделения патологии околощитовидных желез.117036, Москва, ул. Дмитрия Ульянова, д. 11.SPIN-код: 7387-6791</p></bio><bio xml:lang="en"><p>Elena V. Kovaleva.11 Dm. Ulyanova street, 117036 Moscow.SPIN-код: 7387-6791</p></bio><email xlink:type="simple">elen.v.kovaleva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6935-3187</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Айнетдинова</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Ajnetdinova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Айнетдинова Алина Ринатовна - врач-статистик отделения патологии околощитовидных желез.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 9617-7460</p></bio><bio xml:lang="en"><p>Alina R. Ajnetdinova.11 Dm. Ulyanova street, 117036 Moscow.eLibrary SPIN: 9617-7460</p></bio><email xlink:type="simple">9803005@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6667-062X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремкина</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremkina</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремкина Анна Константиновна - кандидат медицинских наук, старший научный сотрудник, и.о. заведующей отделением патологии околощитовидных желез.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 8848-2660</p></bio><bio xml:lang="en"><p>Anna K. Eremkina - PhD.11 Dm. Ulyanova street, 117036 Moscow.eLibrary SPIN: 8848-2660</p></bio><email xlink:type="simple">a.lipatenkova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9717-9742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мокрышева</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Mokrysheva</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мокрышева Наталья Георгиевна - доктор медицинских наук, член-корреспондент, профессор РАН, директор НМИЦ эндокринологии Минздрава России.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 5624-3875</p></bio><bio xml:lang="en"><p>Natalia G. Mokrysheva - MD, PhD.11 Dm. Ulyanova street, 117036 Moscow.eLibrary SPIN: 5624-3875</p></bio><email xlink:type="simple">nm70@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2020</year></pub-date><volume>66</volume><issue>5</issue><fpage>7</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ковалева Е.В., Айнетдинова А.Р., Еремкина А.К., Мокрышева Н.Г., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ковалева Е.В., Айнетдинова А.Р., Еремкина А.К., Мокрышева Н.Г.</copyright-holder><copyright-holder xml:lang="en">Kovaleva E.V., Ajnetdinova A.R., Eremkina A.K., Mokrysheva N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/12675">https://www.probl-endojournals.ru/jour/article/view/12675</self-uri><abstract><p>ОБОСНОВАНИЕ. Ввиду неуклонного роста заболеваемости патологиями щитовидной, околощитовидных желез и других органов шеи, радикальное лечение которых может привести к развитию гипопаратиреоза, прогнозируется значимое увеличение числа больных с данным заболеванием. Оценка эпидемиологических и клинических особенностей хронического гипопаратиреоза необходима для прогнозирования социально значимых осложнений и повышения качества оказания медицинской помощи.ЦЕЛЬ. Оценить клинико-демографические характеристики и эффективность использования различных схем медикаментозной терапии у пациентов с хроническим послеоперационным и нехирургическим гипопаратиреозом с помощью базы данных НМИЦ эндокринологии.МЕТОДЫ. Проведено одномоментное обсервационное сплошное исследование с использованием базы данных пациентов с хроническим послеоперационным и нехирургическим гипопаратиреозом, в которое включены 293 пациента из 61 региона РФ. Анализ данных проведен в июне 2020 г. Количественные признаки представлены медианами (Ме) и квартилями (Q1; Q3); описательная статистика качественных признаков — абсолютными и относительными частотами.РЕЗУЛЬТАТЫ. По результатам анализа базы данных, чаще всего гипопаратиреоз зафиксирован у женщин (85%) в возрасте 43 [32; 52] лет после перенесенного хирургического вмешательства по поводу патологии щитовидной железы. Менее половины обследованных пациентов имеют целевые показатели кальция и фосфора сыворотки крови (31 и 47% соответственно), несмотря на проводимое лечение. Полноценное инструментальное обследование, позволяющее составить полную картину наличия осложнений, проведено в 58% случаев (n=169). Нарушения со стороны почек выявлены у 38%, органов зрения — у 14%, кальцификация головного мозга — у 10%, изменения сердечного ритма — у 4% и психоневрологического статуса — у 6% пациентов. Стандартную терапию (комбинацию активных метаболитов/аналогов витамина D и препаратов кальция) принимали 75% пациентов.ЗАКЛЮЧЕНИЕ. Анализ крупных баз данных пациентов с хроническим гипопаратиреозом — необходимый инструмент для определения прогностических маркеров, в том числе с целью профилактики развития инвалидизирующих осложнений и формирования критериев компенсации заболевания.</p></abstract><trans-abstract xml:lang="en"><sec><title>BACKGRAUND</title><p>BACKGRAUND: Currently high frequency of thyroid or parathyroid surgery is associated with significant increased incidence of hypoparathyroidism. Evaluation of the epidemiological and clinical features of chronic hypoparathyroidism is necessary to predict social-significant complications and to improve the quality of medical care.</p></sec><sec><title>AIMS</title><p>AIMS: To estimate clinical and demographic features, different regimens and efficacy of conventional therapy in patients with chronic postsurgical and nonsurgical hypoparathyroidism.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: The cross-sectional, observational, continuous study was carried out based on Database of patients with chronic postsurgical and nonsurgical hypoparathyroidism of Endocrinology Research Centre, Moscow. 293 patients from 61 regions of the Russian Federation were included in this study. Statistical analysis was done on June 2020. The descriptive statistics are presented by medians (Ме) and the first and third quartiles (Q1; Q3) and by absolute and relative frequencies.</p></sec><sec><title>RESULTS</title><p>RESULTS: Hypoparathyroidism was most often recorded in women (85%) at the age of 43 [32; 52] years, after thyroid surgery. Less than a half of the study group had target indicators of serum calcium and phosphate levels (31% and 47%, respectively) despite ongoing treatment. A complex instrumental examination for the disease complications was performed in 58% of cases (n = 169). Among them, kidney disorders were detected in 38%, visual disturbance in 14%, brain calcification in 10%, arrhythmias in 4% and neuropsychiatric symptoms in 6%. Conventional therapy with calcium supplements and activated vitamin D analogues was noted in 75% of patients.</p></sec><sec><title>CONCLUSIONS</title><p>CONCLUSIONS: The analysis of large databases of patients with chronic hypoparathyroidism is a necessary tool for determining of optimal clinical and therapeutic approaches, as well as prognostic markers of disease complications.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гипопаратиреоз</kwd><kwd>гипокальциемия</kwd><kwd>терапия</kwd><kwd>кальций</kwd><kwd>витамин D</kwd><kwd>тиреоидэктомия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypoparathyroidism</kwd><kwd>hypocalcaemia</kwd><kwd>therapy</kwd><kwd>calcium</kwd><kwd>vitamin D</kwd><kwd>thyroidectomy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данное исследование выполнено в рамках государственного задания «Всероссийский реестр пациентов с хроническим гипопаратиреозом как основа оптимизации и внедрения персонализированного подхода для улучшения качества оказания медицинской помощи населению Российской Федерации», регистрационный номер НИОКТРАААА-А20-120011790168-2.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Powers J, et al. Prevalence and incidence of hypoparathyroidism in the United States Using a large claims database. J. Bone Miner. Res. 2013;28(12):2570-2576. doi:10.1002/jbmr.2004.</mixed-citation><mixed-citation xml:lang="en">Powers J, et al. Prevalence and incidence of hypoparathyroidism in the United States Using a large claims database. J. Bone Miner. Res. 2013;28(12):2570-2576. doi:10.1002/jbmr.2004.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Abate EG, Clarke BL. Review of Hypoparathyroidism. Front. Endocrinol. (Lausanne). 2016;7:172. doi:10.3389/fendo.2016.00172.</mixed-citation><mixed-citation xml:lang="en">Abate EG, Clarke BL. Review of Hypoparathyroidism. Front. Endocrinol. (Lausanne). 2016;7:172. doi:10.3389/fendo.2016.00172.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Iqbal K, et al. Defining the Characteristics of Chronic Hypoparathyroidism Not Adequately Controlled on Conventional Therapy: Consensus Findings of Three European Delphi Panels. Adv. Ther. 2019;36(11):3007-3016. doi:10.1007/s12325-019-01102-5.</mixed-citation><mixed-citation xml:lang="en">Iqbal K, et al. Defining the Characteristics of Chronic Hypoparathyroidism Not Adequately Controlled on Conventional Therapy: Consensus Findings of Three European Delphi Panels. Adv. Ther. 2019;36(11):3007-3016. doi:10.1007/s12325-019-01102-5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bollerslev J, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur. J. Endocrinol. 2015;173(2). doi: 10.1530/EJE-15-0628.</mixed-citation><mixed-citation xml:lang="en">Bollerslev J, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur. J. Endocrinol. 2015;173(2). doi: 10.1530/EJE-15-0628.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AA, et al. Standards of care for hypoparathyroidism in adults: A Canadian and international consensus. Eur. J. Endocrinol. 2019;180(3):1-P22. doi:10.1530/EJE-18-0609.</mixed-citation><mixed-citation xml:lang="en">Khan AA, et al. Standards of care for hypoparathyroidism in adults: A Canadian and international consensus. Eur. J. Endocrinol. 2019;180(3):1-P22. doi:10.1530/EJE-18-0609.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell DM, et al. Long-term follow-up of patients with hypoparathyroidism. J. Clin. Endocrinol. Metab. 2012;97(12):4507-4514. doi:10.1210/jc.2012-1808.</mixed-citation><mixed-citation xml:lang="en">Mitchell DM, et al. Long-term follow-up of patients with hypoparathyroidism. J. Clin. Endocrinol. Metab. 2012;97(12):4507-4514. doi:10.1210/jc.2012-1808.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shoback DM, et al. Presentation of hypoparathyroidism: Etiologies and clinical features. J. Clin. Endocrinol. Metab. 2016;101(6):2300-2312. doi:10.1210/jc.2015-3909.</mixed-citation><mixed-citation xml:lang="en">Shoback DM, et al. Presentation of hypoparathyroidism: Etiologies and clinical features. J. Clin. Endocrinol. Metab. 2016;101(6):2300-2312. doi:10.1210/jc.2015-3909.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Underbjerg L, et al. Postsurgical hypoparathyroidism-Risk of fractures, Psychiatric Diseases, Cancer, Cataract, and Infections. J. Bone Miner. Res. 2014;29(S1):2504-2510. doi:10.1002/jbmr.2273.</mixed-citation><mixed-citation xml:lang="en">Underbjerg L, et al. Postsurgical hypoparathyroidism-Risk of fractures, Psychiatric Diseases, Cancer, Cataract, and Infections. J. Bone Miner. Res. 2014;29(S1):2504-2510. doi:10.1002/jbmr.2273.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Levy I, et al. The impact of hypoparathyroidism treatment on the kidney in children: Long-term retrospective follow-up study. J. Clin. Endocrinol. Metab. 2015;100(11):4106-4113. doi:10.1210/jc.2015-2257.</mixed-citation><mixed-citation xml:lang="en">Levy I, et al. The impact of hypoparathyroidism treatment on the kidney in children: Long-term retrospective follow-up study. J. Clin. Endocrinol. Metab. 2015;100(11):4106-4113. doi:10.1210/jc.2015-2257.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Daba KT, Weldemichael DK, Mulugeta GA. Bilateral hypocalcemic cataract after total thyroidectomy in a young woman: case report. BMC Ophthalmol. 2019;19(1):233. doi:10.1186/s12886-019-1224-9.</mixed-citation><mixed-citation xml:lang="en">Daba KT, Weldemichael DK, Mulugeta GA. Bilateral hypocalcemic cataract after total thyroidectomy in a young woman: case report. BMC Ophthalmol. 2019;19(1):233. doi:10.1186/s12886-019-1224-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Saha S, et al. Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status. J. Bone Miner. Metab. 2017;35(4):405-411. doi:10.1007/s00774-016-0767-6.</mixed-citation><mixed-citation xml:lang="en">Saha S, et al. Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status. J. Bone Miner. Metab. 2017;35(4):405-411. doi:10.1007/s00774-016-0767-6.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Goswami R, et al. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin. Endocrinol. (Oxf). 2012;77(2):200-206. doi:10.1111/j.1365-2265.2012.04353.x.</mixed-citation><mixed-citation xml:lang="en">Goswami R, et al. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin. Endocrinol. (Oxf). 2012;77(2):200-206. doi:10.1111/j.1365-2265.2012.04353.x.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Newman DB, et al. Reversible cardiac dysfunction associated with hypocalcemia: A systematic review and meta-analysis of individual patient data. Heart Fail. Rev. 2014;19(2):199-205. doi:10.1007/s10741-013-9371-1.</mixed-citation><mixed-citation xml:lang="en">Newman DB, et al. Reversible cardiac dysfunction associated with hypocalcemia: A systematic review and meta-analysis of individual patient data. Heart Fail. Rev. 2014;19(2):199-205. doi:10.1007/s10741-013-9371-1.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SH, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS One. 2020;15(5):e0232842. https://doi.org/10.1371/journal.pone.0232842.</mixed-citation><mixed-citation xml:lang="en">Kim SH, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS One. 2020;15(5):e0232842. https://doi.org/10.1371/journal.pone.0232842.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Underbjerg L, et al. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 2013;28(1 1):2277-2285. doi:10.1002/jbmr.1979.</mixed-citation><mixed-citation xml:lang="en">Underbjerg L, et al. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 2013;28(1 1):2277-2285. doi:10.1002/jbmr.1979.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Jensterle M, et al. Dihydrotachysterol intoxication treated with pamidronate: a case report. Cases J. 2010;3(1):78. doi:10.1186/1757-1626-3-78.</mixed-citation><mixed-citation xml:lang="en">Jensterle M, et al. Dihydrotachysterol intoxication treated with pamidronate: a case report. Cases J. 2010;3(1):78. doi:10.1186/1757-1626-3-78.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Quack I, et al. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review. Exp. Clin. Endocrinol. diabetes Off. journal, Ger. Soc. Endocrinol. [and] Ger. Diabetes Assoc. Germany, 2005;113(7):376-380. doi:10.1055/s-2005-865724.</mixed-citation><mixed-citation xml:lang="en">Quack I, et al. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review. Exp. Clin. Endocrinol. diabetes Off. journal, Ger. Soc. Endocrinol. [and] Ger. Diabetes Assoc. Germany, 2005;113(7):376-380. doi:10.1055/s-2005-865724.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Garda-Pascual L, et al. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism. J. Clin. Endocrinol. Metab. United States, 2017;102(1):259-266. doi:10.1210/jc.2016-2987.</mixed-citation><mixed-citation xml:lang="en">Garda-Pascual L, et al. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism. J. Clin. Endocrinol. Metab. United States, 2017;102(1):259-266. doi:10.1210/jc.2016-2987.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Winer K.K, et al. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism. J. Pediatr. 2018;203):391-399.e1. doi:10.1016/j.jpeds.2018.08.010.</mixed-citation><mixed-citation xml:lang="en">Winer K.K, et al. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism. J. Pediatr. 2018;203):391-399.e1. doi:10.1016/j.jpeds.2018.08.010.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mannstadt M, et al. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. J. Clin. Endocrinol. Metab. 2019;104(11):5136-5147. doi:10.1210/jc.2019-01010.</mixed-citation><mixed-citation xml:lang="en">Mannstadt M, et al. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. J. Clin. Endocrinol. Metab. 2019;104(11):5136-5147. doi:10.1210/jc.2019-01010.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
